351 related articles for article (PubMed ID: 36359742)
1. Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.
Xue E; Minniti A; Alexander T; Del Papa N; Greco R; On Behalf Of The Autoimmune Diseases Working Party Adwp Of The European Society For Blood And Marrow Transplantation Ebmt
Cells; 2022 Oct; 11(21):. PubMed ID: 36359742
[TBL] [Abstract][Full Text] [Related]
2. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis.
Del Papa N; Pignataro F; Zaccara E; Maglione W; Minniti A
Front Immunol; 2018; 9():2390. PubMed ID: 30386340
[TBL] [Abstract][Full Text] [Related]
3. Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis.
Velier M; Daumas A; Simoncini S; Arcani R; Magalon J; Benyamine A; Granel B; Dignat George F; Chabannon C; Sabatier F
Bone Marrow Transplant; 2022 Jan; 57(1):17-22. PubMed ID: 34663928
[TBL] [Abstract][Full Text] [Related]
4. Cellular Therapies in Systemic Sclerosis: Recent Progress.
van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM
Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351
[TBL] [Abstract][Full Text] [Related]
5. Autologous hematopoietic stem cell transplantation for systemic sclerosis.
Milanetti F; Bucha J; Testori A; Burt RK
Curr Stem Cell Res Ther; 2011 Mar; 6(1):16-28. PubMed ID: 20955159
[TBL] [Abstract][Full Text] [Related]
6. Autologous stem cell transplantation in scleroderma.
Farge D; Ait Abdallah N; Marjanovic Z; Del Papa N
Presse Med; 2021 Apr; 50(1):104065. PubMed ID: 33548374
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells for systemic sclerosis treatment.
Farge D; Loisel S; Lansiaux P; Tarte K
Autoimmun Rev; 2021 Mar; 20(3):102755. PubMed ID: 33476823
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges.
Peltzer J; Aletti M; Frescaline N; Busson E; Lataillade JJ; Martinaud C
Front Immunol; 2018; 9():2013. PubMed ID: 30271402
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of mesenchymal stromal cell transplantation in systemic scleroderma].
Lansiaux P; Farge D
Rev Prat; 2022 Apr; 72(4):355-362. PubMed ID: 35638974
[TBL] [Abstract][Full Text] [Related]
10. New pathogenic and therapeutic concepts in systemic sclerosis.
Hügle T; Huigens CA; van Laar JM
Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
[TBL] [Abstract][Full Text] [Related]
11. Case report: A successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation.
Haverkort DA; Kersten BE; van Rhenen A; van der Velden WJFM; Vonk MC
Front Immunol; 2022; 13():925776. PubMed ID: 36505455
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell-Based Therapy as a New Approach for the Treatment of Systemic Sclerosis.
Zhuang X; Hu X; Zhang S; Li X; Yuan X; Wu Y
Clin Rev Allergy Immunol; 2023 Jun; 64(3):284-320. PubMed ID: 35031958
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic Cell Transplantation for Systemic Sclerosis-A Review.
Levin D; Osman MS; Durand C; Kim H; Hemmati I; Jamani K; Howlett JG; Johannson KA; Weatherald J; Woo M; Lee J; Storek J
Cells; 2022 Dec; 11(23):. PubMed ID: 36497169
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis.
Kawashima-Vasconcelos MY; Santana-Gonçalves M; Zanin-Silva DC; Malmegrim KCR; Oliveira MC
Front Immunol; 2022; 13():941011. PubMed ID: 36032076
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
16. Strategy for treatment of fibrosis in systemic sclerosis: Present and future.
Yanaba K
J Dermatol; 2016 Jan; 43(1):46-55. PubMed ID: 26782006
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplant in systemic sclerosis: An Indian experience.
Nair V; Vasdev V; Kumar A; Shankar S; Nair V; Sharma A
Int J Rheum Dis; 2018 Apr; 21(4):859-865. PubMed ID: 29392863
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party.
Henes J; Oliveira MC; Labopin M; Badoglio M; Scherer HU; Del Papa N; Daikeler T; Schmalzing M; Schroers R; Martin T; Pugnet G; Simoes B; Michonneau D; Marijt EWA; Lioure B; Olivier Bay J; Snowden JA; Rovira M; Huynh A; Onida F; Kanz L; Marjanovic Z; Farge D
Haematologica; 2021 Feb; 106(2):375-383. PubMed ID: 31949011
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.
Di Benedetto P; Ruscitti P; Cipriani P; Giacomelli R
Autoimmun Rev; 2020 Nov; 19(11):102662. PubMed ID: 32942028
[TBL] [Abstract][Full Text] [Related]
20. Improving outcomes in scleroderma: recent progress of cell-based therapies.
Khanna D; Krieger N; Sullivan KM
Rheumatology (Oxford); 2023 Jun; 62(6):2060-2069. PubMed ID: 36355455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
